Updated September 2026A discounted first monthMaves review
The $89 on the page is a first month with a $100 discount applied, and every month after it costs $189.
The verdict
Maves sells compounded semaglutide at $189 a month, and the $89 that leads its product page is that same monthly plan with a $100 first-order discount applied automatically at checkout. From the second month onward the page's own figure is $189, with no membership fee on top and cancellation allowed at any time through the patient portal.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide
- Form
- Injection
- States
- 50
- From
- From $189/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Maves is a telehealth brand selling compounded semaglutide and tirzepatide alongside sermorelin and NAD+, and it frames weight loss as a sequence of phases that runs from an induction period through active fat loss to a taper toward maintenance.
Who writes the prescription, and what do they see?
The page says licensed clinicians prescribe every treatment after an online assessment, and that a provider writes a plan only when medication is judged appropriate for the patient. No prescriber, medical group or licensing state is named on the product pages, so a buyer first meets the clinician somewhere inside the intake rather than on the page.
Once a prescription is written, the care described is built around messaging: clinicians reachable at any hour without booking an appointment, dose adjustments made through that same channel, and ondansetron prescribed for nausea when a patient needs it. The medication ships free by expedited delivery, and the formulation may include vitamin B12 or L-carnitine alongside the semaglutide, which the page presents as part of personalizing the treatment.
What happens when the dose goes up?
The page says Maves starts low and titrates for comfort, and it describes a later step down toward maintenance, but it does not publish a milligram schedule in either direction. The $189 is a single monthly figure with no dose attached, and whether it holds as the dose climbs through the first few months is not stated anywhere on the page.
What the price includes
The plan is monthly, and no longer commitment rung is published, so the arithmetic is simple once the first month is set aside as the exception it is. Six months at the standing $189 would come to $1,134, and the first-order discount takes $100 off that total once rather than every month.
What it claims, and what it cites
Both GLP-1 lines are compounded by licensed U.S. pharmacies, which the page describes as state-licensed or FDA-registered outsourcing facilities whose products are tested by a third party for purity and potency, though none of them is named. Compounded semaglutide is not FDA-approved, and a reader should know that the page's own FAQ calls semaglutide FDA-approved, which is true of the branded medicine rather than the compounded one sold here.
Where it holds up, and where it does not
- Strength: The first-month condition is printed beside the price
- Strength: No membership fee on top of $189
- Strength: Anti-nausea prescribing is named in the FAQ
- Strength: Cancellation at any time, stated in writing
- Limitation: The headline $89 lasts a single month
- Limitation: No milligram dose or schedule is published
- Limitation: Pharmacies are described but never named
- Limitation: The FAQ blurs compounded and FDA-approved semaglutide
What the evidence says about this kind of treatment
The assessment above is about Maves. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who budgets on $189 a month and treats the $89 as a one-time discount on the first order.
- Wrong for
- A reader who wants a published dose schedule, or a named prescriber, before placing the first order.
How Maves compares
| Seller | Who it suits | Go |
|---|---|---|
 Regenics | Readers who will add the membership to the medication before comparing anything | See Regenics → |
 Sprout Health | Readers taking the six-month plan, which is the one measured in calendar months | See Sprout Health → |
 Rivas Medical Weight Loss | Buyers within reach of a clinic who want a clinician present every week | See Rivas Medical Weight Loss → |
More GLP-1 telehealth sellers reviews: TryoziTuyo HealthVaylenVevaRXVigorMedsVirtualCare2Go
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Is $89 the monthly price?
- It is the first month only, with a $100 first-order discount applied automatically at checkout, and the same pricing block states $189 a month for every month after that.
- Is there a contract?
- The FAQ says plans are subscriptions that can be canceled at any time through the patient portal, with no long-term contract and no cancellation fee, although an order already sent to the pharmacy still goes out.
- Does Maves sell tirzepatide?
- Yes, on its own product page, and that page carries the same $100 first-order discount structure, with a higher monthly figure than the semaglutide plan once the first month has passed.
- Is Maves expensive compared with other GLP-1 telehealth sellers?
- Maves publishes a starting figure of $189/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts Maves right at the median. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.